PHG
Koninklijke Philips N.V. (NYSE)
Healthcare — Medical Devices
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Price History
Fundamentals
| Market Cap | $26.44B |
| P/E Ratio (TTM) | 23.86 |
| Forward P/E | 13.47 |
| EPS (TTM) | $1.14 |
| Dividend Yield | 3.72% |
| Profit Margin | 5.50% |
| Revenue Growth | -4.70% |
| ROE | 8.36% |
| Debt/Equity | 70.91 |
| Recommendation | Hold 2.6 |
| Analyst Target | $33.26 |
| Analysts | 5 |
| Indexes | NYSE |
Technical Indicators
| RSI (14) | 70.1 |
| Beta | 0.93 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $33.44 |
| 52-Week Low | $23.75 |
| 50-Day Avg | $26.61 |
| 200-Day Avg | $27.95 |
| Avg Volume | $1.16M |
| Volume | 660.9K |
Performance Analysis
NEUTRALPHG presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:26 UTC
Back to Screener Export Report